Conversation

Replying to
The vision of @SGottliebFDA to jointly facilitiate innovation and improve #ptsafety is admirable. Making progress on both is possible, and both rely on better, more efficient ways to collect data on product safety, effectivness & quality. That sentiment weaves through the plan 2/
1
Use of device IDs serve as a key thread tying the plan together. However, creation of UDIs is not enough. They need to be integrated into different data systems to reach their potential 3/
1
“UDI provides a standard and clear way to document device use, including in electronic health records, clinical information systems, claims data sources, and registries.” Progress being made here. Need continued suport from & to advance device IDs in claims 4/
1
1
. also described as a cornerstone to a robust safety network, to link data sources and leverage the strengths of each data source to address deficiencies in others FDA seeking to use $ in President's Budget for "New Medical Data Enterprise" to support NEST 5/
1
1
FDA pitches reorganization of CDRH to merge premarket/postmarket responsibilities, and regroup in to total product life cycle teams according to device type 9/
1
1
In sum: The FDA report has several key insights and next steps. Importantly, the plan emphasizes the need for better data using modern systems to evaluate device performance--that's a theme that can help detect safety concerns faster & get innovative devices to patients 10/end